Cello Health plc Share Price

CLL

GB00B0310763

Delayed London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-0.31%	+19.70%

11/08	Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/11	Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI

News in other languages: Cello Health plc

01/20/01

Cello Health plc : OPA

More news

Managers and Directors: Cello Health plc

Manager	Title	Age	Since
Rebecca Hyde COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Jon Williams BRD	Director/Board Member	51	13/08/2020
Michael Madden BRD	Director/Board Member	47	15/12/2023

More insiders

Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.

Employees

Sector

More about the company

Market Cap	18Cr 24Cr 21Cr 20Cr 33Cr 2.27TCr 34Cr 235.37Cr 94Cr 1.2TCr 90Cr 88Cr 3.77TCr	P/E 2024	43.4x	P/E 2025	-109x
Enterprise Value	18Cr 24Cr 21Cr 20Cr 33Cr 2.28TCr 34Cr 235.43Cr 95Cr 1.2TCr 90Cr 88Cr 3.77TCr	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	-	Yield 2024 *	-	Yield 2025	-

11/08	Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/11	Cello Health Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
11/20/11	Value Demonstration UK Holdings Limited completed the acquisition of Cello Health plc.	CI
01/20/01	Value Demonstration UK Holdings Limited reached an agreement to acquire Cello Health plc for approximately £170 million.	CI
04/20/04	Access Intelligence Plc commences an Equity Buyback Plan for 4,076,238 shares, for £0.000001 million, under the authorization approved on May 20, 2020.	CI
04/20/04	Tranche Update on Access Intelligence Plc's Equity Buyback Plan announced on June 4, 2020.	CI
04/20/04	Access Intelligence Plc's Equity Buyback announced on February 6, 2020, has closed with 4,076,238 shares, for £1 million.	CI
21/20/21	Cello Health plc Withdraws Recommendation to Pay Final Dividend	CI
07/20/07	Cello Health plc Withdraws Final Dividend; Declares Interim Dividend, Payable on May 22, 2020	CI
18/20/18	Cello Health plc Proposes Final Dividend, Payable on May 22, 2020	CI
18/20/18	Cello Health plc Reports Earnings Results for the Full Year Ended December 31, 2019	CI
02/19/02	Access Intelligence Plc acquired Fenix Media Limited and Face US Inc. from Cello Health plc and Cello Health Inc. for £4.7 million.	CI
18/19/18	Cello Health plc Announces Interim Dividend, Payable on November 1, 2019	CI

11/20/11	Killik & Co. LLP : - Form 8.3 - Cello Health Plc	PR
28/20/28	Cello Health : Form 8.3 - - (HHL)	AQ
10/20/10	Premier Miton Group Plc : - Form 8.3 - Cello Health Plc	PR
08/20/08	Premier Miton Group Plc : - Form 8.3 - Cello Health Plc	PR
07/20/07	Killik & Co. LLP : - Form 8.3 - Cello Health Plc	PR

Date	Insider	Type	Main position	Quantity	% Market Cap.
30/03/20	Jane Shirley	Free		80,000	0.0752%
30/03/20	Stephen Martin Highley	Free	Chief Operating Officer	2,65,000	0.2492%
30/03/20	Mark Bentley	Free	Chief Financial Officer	2,50,000	0.2351%

	2024	2025
Net sales	-	-
Net income	41.25L 55.26L 49.49L 45.53L 77.11L 52Cr 78.55L 5.43Cr 2.18Cr 28Cr 2.07Cr 2.03Cr 87Cr	-16.36L -21.92L -19.63L -18.06L -30.58L -21Cr -31.15L -2.15Cr -86.44L -11Cr -82.25L -80.5L -35Cr
Net Debt	13.41L 17.97L 16.09L 14.8L 25.07L 17Cr 25.54L 1.76Cr 70.85L 8.97Cr 67.42L 65.99L 28Cr	42T 56.27T 50.39T 46.35T 78.51T 53.43L 79.98T 6L 2L 28.1L 2L 2L 88.63L

Cello Health plc Share Price

Stocks

CLL

GB00B0310763

Valuation: Cello Health plc

Latest news: Cello Health plc

Press Releases: Cello Health plc

News in other languages: Cello Health plc

Managers and Directors: Cello Health plc

Latest insider transactions

Financials

Company Profile